Showing results (301-310 of 415) with videos related to

Sort By:
Pageof 42
Blood|June 13, 2019
Brentuximab vedotin, doxorubicin, vinblastine, and dacarbazine for nonbulky limited-stage classical Hodgkin lymphomaJeremy S Abramson, Jon E Arnason, Ann S LaCasce, et al.
Mucosal Immunology|August 28, 2009
Link between allergic asthma and airway mucosal infection suggested by proteinase-secreting household fungiP Porter, S C Susarla, S Polikepahad, et al.
Cancer Research Communications|March 16, 2023
A Phase I Study of Pelabresib (CPI-0610), a Small-Molecule Inhibitor of BET Proteins, in Patients with Relapsed or Refractory LymphomaKristie A Blum, Jeffrey G Supko, Michael B Maris, et al.
Blood Cancer Journal|November 1, 2022
Effect of granulocyte colony-stimulating factor on toxicities after CAR T cell therapy for lymphoma and myelomaKevin Charles Miller, Patrick Connor Johnson, Jeremy S Abramson, et al.
Haematologica|November 13, 2012
Everolimus in combination with rituximab induces complete responses in heavily pretreated diffuse large B-cell lymphomaJeffrey A Barnes, Eric Jacobsen, Yang Feng, et al.
The American Journal of Cardiology|June 15, 2015
Major Cardiac Events and the Value of Echocardiographic Evaluation in Patients Receiving Anthracycline-Based ChemotherapyLin Wang, Timothy C Tan, Elkan F Halpern, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|July 14, 2011
Autologous stem cell transplantation with thiotepa, busulfan, and cyclophosphamide (TBC) conditioning in patients with CNS involvement by non-Hodgkin lymphomaGregory M Cote, Ephraim P Hochberg, Alona Muzikansky, et al.
American Journal of Hematology|July 16, 2016
The immunophenotypic spectrum of primary mediastinal large B-cell lymphoma reveals prognostic biomarkers associated with outcomeJacob R Bledsoe, Robert A Redd, Robert P Hasserjian, et al.
Blood Advances|September 27, 2023
Ibrutinib maintenance after frontline treatment in patients with mantle cell lymphomaReem Karmali, Jeremy S Abramson, Deborah M Stephens, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 1, 1996
Sequential methotrexate and fluorouracil for the treatment of node-negative breast cancer patients with estrogen receptor-negative tumors: eight-year results from National Surgical Adjuvant Breast and Bowel Project (NSABP) B-13 and first report of findings from NSABP B-19 comparing methotrexate and fluorouracil with conventional cyclophosphamide, methotrexate, and fluorouracilB Fisher, J Dignam, E P Mamounas, et al.
Pageof 42